Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1986 1
1987 4
1988 2
1989 2
1990 1
1993 1
1994 2
1995 1
1996 6
1997 4
1998 3
1999 6
2000 6
2001 8
2002 5
2003 7
2004 2
2005 3
2006 8
2007 7
2008 4
2009 6
2010 2
2012 1
2013 2
2014 3
2015 4
2016 2
2017 4
2018 2
2019 5
2020 7
2021 9
2022 13
2023 12
2024 8
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Results by year

Filters applied: . Clear all
Page 1
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, Yamamoto A, Mukai R, Honjyo J, Maruko I, Kawai M, Miyara Y, Terao N, Wakatsuki Y, Onoe H, Mori R, Koizumi H, Sekiryu T, Iida T, Okada AA; for Japan AMD Research Consortium (JARC). Kataoka K, et al. Among authors: wakatsuki y. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):43-51. doi: 10.1007/s00417-023-06222-x. Epub 2023 Sep 5. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37668741
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan.
Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, Watanabe Y, Yamamoto A, Wakatsuki Y, Onoe H, Wakugawa S, Terao N, Hasegawa T, Hashiya N, Kawai M, Maruko R, Itagaki K, Honjo J, Okada AA, Mori R, Koizumi H, Iida T, Sekiryu T. Mukai R, et al. Among authors: wakatsuki y. Sci Rep. 2023 May 30;13(1):8747. doi: 10.1038/s41598-023-35759-4. Sci Rep. 2023. PMID: 37253802 Free PMC article.
Acquired Vitelliform Lesions in Intermediate Age-Related Macular Degeneration: A Cross Sectional Study.
Lindenberg S, Mahmoudi A, Oncel D, Corradetti G, Oncel D, Emamverdi M, Almidani L, Farahani A, Wakatsuki Y, He Y, Saju M S, Lee WK, Wykoff CC, Sarraf D, Freund KB, Sadda SR. Lindenberg S, et al. Among authors: wakatsuki y. Ophthalmol Retina. 2024 Sep;8(9):854-862. doi: 10.1016/j.oret.2024.04.009. Epub 2024 Apr 16. Ophthalmol Retina. 2024. PMID: 38631656
Genome-Wide Association Study of Age-Related Macular Degeneration Reveals 2 New Loci Implying Shared Genetic Components with Central Serous Chorioretinopathy.
Akiyama M, Miyake M, Momozawa Y, Arakawa S, Maruyama-Inoue M, Endo M, Iwasaki Y, Ishigaki K, Matoba N, Okada Y, Yasuda M, Oshima Y, Yoshida S, Nakao SY, Morino K, Mori Y, Kido A, Kato A, Yasukawa T, Obata R, Nagai Y, Takahashi K, Fujisawa K, Miki A, Nakamura M, Honda S, Ushida H, Yasuma T, Nishiguchi KM, Mori R, Tanaka K, Wakatsuki Y, Yamashiro K, Kadonosono K, Terao C, Ishibashi T, Tsujikawa A, Sonoda KH, Kubo M, Kamatani Y. Akiyama M, et al. Among authors: wakatsuki y. Ophthalmology. 2023 Apr;130(4):361-372. doi: 10.1016/j.ophtha.2022.10.034. Epub 2022 Nov 22. Ophthalmology. 2023. PMID: 36423732
One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in Japan.
Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, Watanabe Y, Yamamoto A, Wakatsuki Y, Onoe H, Wakugawa S, Terao N, Hasegawa T, Kawai M, Maruko R, Itagaki K, Honjo J, Okada AA, Mori R, Koizumi H, Iida T, Sekiryu T. Mukai R, et al. Among authors: wakatsuki y. Sci Rep. 2024 May 22;14(1):11681. doi: 10.1038/s41598-024-62559-1. Sci Rep. 2024. PMID: 38778065 Free PMC article.
Usefulness of Practitioner-Led Pancreatic Cancer Screening.
Matsumoto K, Kushiyama Y, Izumi A, Ohnishi K, Miura M, Ohuchi Y, Hori I, Nakamura T, Hori K, Koshino K, Kobayashi J, Yoshino N, Hoshino U, Okumura T, Tanimura T, Tanaka S, Tanaka S, Nabika T, Nozu T, Wakatsuki Y, Katayama S, Yoshioka S, Ito K, Uchida A, Yuhara N, Noma H, Isomoto H. Matsumoto K, et al. Among authors: wakatsuki y. Diagnostics (Basel). 2022 Sep 19;12(9):2257. doi: 10.3390/diagnostics12092257. Diagnostics (Basel). 2022. PMID: 36140658 Free PMC article.
Oxidized-LDL and atherosclerosis. Role of LOX-1.
Kita T, Kume N, Yokode M, Ishii K, Arai H, Horiuchi H, Moriwaki H, Minami M, Kataoka H, Wakatsuki Y. Kita T, et al. Among authors: wakatsuki y. Ann N Y Acad Sci. 2000 May;902:95-100; discussion 100-2. doi: 10.1111/j.1749-6632.2000.tb06304.x. Ann N Y Acad Sci. 2000. PMID: 10865829 Review.
SLIViT: a general AI framework for clinical-feature diagnosis from limited 3D biomedical-imaging data.
Avram O, Durmus B, Rakocz N, Corradetti G, An U, Nitalla MG, Rudas A, Wakatsuki Y, Hirabayashi K, Velaga S, Tiosano L, Corvi F, Verma A, Karamat A, Lindenberg S, Oncel D, Almidani L, Hull V, Fasih-Ahmad S, Esmaeilkhanian H, Wykoff CC, Rahmani E, Arnold CW, Zhou B, Zaitlen N, Gronau I, Sankararaman S, Chiang JN, Sadda SR, Halperin E. Avram O, et al. Among authors: wakatsuki y. Res Sq [Preprint]. 2023 Nov 21:rs.3.rs-3044914. doi: 10.21203/rs.3.rs-3044914/v2. Res Sq. 2023. Update in: Nat Biomed Eng. 2024 Oct 1. doi: 10.1038/s41551-024-01257-9 PMID: 38045283 Free PMC article. Updated. Preprint.
Hyperthymic temperament predicts neural responsiveness for monetary reward.
Ogura Y, Wakatsuki Y, Hashimoto N, Miyamoto T, Nakai Y, Toyomaki A, Tsuchida Y, Nakagawa S, Inoue T, Kusumi I. Ogura Y, et al. Among authors: wakatsuki y. J Affect Disord. 2023 Jan 1;320:674-681. doi: 10.1016/j.jad.2022.09.154. Epub 2022 Oct 5. J Affect Disord. 2023. PMID: 36206884
147 results